Erythromer

ErythroMer is a blood substitute in development funded by the NIH and Department of Defense.^[1] It is novel in that unlike other blood substitutes, Perfluorocarbon-Based Oxygen Carriers (PBOCs) and Cell-Free Hemoglobin Based Carriers (HBOCs), it is stored lyophilized and reconstituted when needed in emergency situations.^[2] The product is stable for several months.

The development of this technology was done at Washington University at St. Louis and UIUC.^[3] Trials have been successful in rats, mice, and rabbits, and human trials are planned.^[4]

References

^ "Grants and Contracts | Anesthesia Faculty Scholarship Newsletter | Perelman School of Medicine at the University of Pennsylvania". Med.upenn.edu. 2016-09-30. Retrieved 2016-12-03.
^ "5 questions as the world's top blood experts convene". Statnews.com. Retrieved 2016-12-03.
^ "ErythroMer Blood Substitute | Washington University in St. Louis website=Otm.wustl.edu". Retrieved 2016-12-03. {{cite web}}: Missing pipe in: |title= (help)
^ "1027 Erythromer (EM), a Nanoscale Bio-Synthetic Artificial Red Cell: Proof of Concept and In Vivo Efficacy Results". Ash.confex.com. Retrieved 2016-12-03.

This article is a stub. You can help Wikipedia by expanding it.

[1] "Grants and Contracts | Anesthesia Faculty Scholarship Newsletter | Perelman School of Medicine at the University of Pennsylvania". Med.upenn.edu. 2016-09-30. Retrieved 2016-12-03.

[2] "5 questions as the world's top blood experts convene". Statnews.com. Retrieved 2016-12-03.

[3] "ErythroMer Blood Substitute | Washington University in St. Louis website=Otm.wustl.edu". Retrieved 2016-12-03. {{cite web}}: Missing pipe in: |title= (help)

[4] "1027 Erythromer (EM), a Nanoscale Bio-Synthetic Artificial Red Cell: Proof of Concept and In Vivo Efficacy Results". Ash.confex.com. Retrieved 2016-12-03.

[1]

[2]

[3]

[4]